{{Rsnum
|rsid=2064501
|Gene=IL22RA2
|Chromosome=6
|position=137156686
|Orientation=plus
|GMAF=0.3678
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=IL22RA2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 26.5 | 54.0 | 19.5
| HCB | 5.2 | 41.0 | 53.7
| JPT | 8.0 | 54.5 | 37.5
| YRI | 0.7 | 15.9 | 83.4
| ASW | 3.5 | 19.3 | 77.2
| CHB | 5.2 | 41.0 | 53.7
| CHD | 5.7 | 42.5 | 51.9
| GIH | 10.9 | 50.5 | 38.6
| LWK | 0.0 | 11.2 | 88.8
| MEX | 33.3 | 47.4 | 19.3
| MKK | 1.3 | 16.7 | 82.1
| TSI | 15.7 | 56.9 | 27.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=21659360
|Title=Association between single nucleotide polymorphism-genotype and outcome of patients with chronic lymphocytic leukemia in a randomized chemotherapy trial
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}